Patricia D Hurn

Title: **The Innovative Contributions of Patricia D. Hurn**

Introduction

Patricia D. Hurn, a prominent inventor based in Portland, Oregon, has made significant strides in the field of medical innovations aimed at treating stroke. With a total of three patents to her name, her work stands out for its potential impact on the modulation of T-cell activities, particularly in conditions related to central nervous system damage.

Latest Patents

Among Patricia D. Hurn's latest innovations are her patents focused on compositions and methods utilizing recombinant MHC molecules for stroke treatment. These inventions introduce two-domain MHC polypeptides that are designed to modulate the activities of antigen-specific T-cells. The exemplary MHC class II-based recombinant T-cell ligands (RTLs) feature covalently linked β1 and α1 domains, while MHC class I-based molecules incorporate covalently linked α1 and α2 domains. These versatile polypeptides can also include covalently linked antigenic determinants, toxic moieties, and detectable labels. They serve multiple purposes: from detecting and purifying antigen-specific T-cells to inducing or activating T-cells, and modulating T-cell activities by influencing cytokine and adhesion molecule expression. Ultimately, they aim to address conditions mediated by antigen-specific T-cells, especially in treating and preventing stroke-related central nervous system damage.

Career Highlights

Patricia has collaborated with leading institutions throughout her career, including the Oregon Health & Science University and the United States Department of Veterans Affairs. Her work has positioned her as a key figure in research aimed at understanding and combatting the effects of strokes, thereby contributing to advancements in medical science and patient care.

Collaborations

Throughout her professional journey, Patricia has worked alongside distinguished colleagues, including Halina Offner and Arthur A. Vandenbark. Together, they have contributed to groundbreaking research that aims to improve treatment modalities for patients affected by stroke, highlighting the importance of teamwork in the field of innovation.

Conclusion

Patricia D. Hurn embodies the spirit of innovation in medical research. Her contributions through her patents signify a hopeful advancement in the treatment of strokes, potentially changing the landscape for patients affected by such conditions. With continued dedication and collaborative efforts, her work promises to leave a lasting impact in the medical community.